Skip to main content

Table 1 Patient characteristics (n = 51)

From: Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer

Characteristic Median (range)
Age 67 (range 52–83)
Length of clinical follow-up (months) 23 (range 8–47)
Time after radiotherapy of the last post-treatment endoscopy (months) 13 (range 1–35)
Characteristic Number (%)
Ethnicity  
 Caucasian 30 (59%)
 African-America 20 (39%)
 Other 1 (2%)
Pre-SBRT use of anticoagulation therapy 11 (22%)
Pre-SBRT hemorrhoids 4 (8%)
Radiotherapy  
 SBRT monotherapy 35 (69%)
 SBRT boost 16 (31%)
Androgen deprivation therapy  
 No 35 (69%)
 Yes 16 (31%)
NCCN risk category  
 Low 14 (27%)
 Intermediate 28 (55%)
 High 9 (18%)
Gleason score  
 6 18 (35%)
 7 24 (47%)
 8 4 (8%)
 9 5 (10%)
T stage  
 1c 28 (55%)
 2a 10 (20%)
 2b 8 (16%)
 2c 5 (10%)
PSA  
 ≤ 10 ng/mL 41 (80%)
 > 10 ng/mL 10 (20%)